Browse

Skin cancer is a disease with an increasing incidence due to its complex etiology and various forms of manifestation. The topical treatment can be a successful therapeutic approach in early diagnosed cutaneous neoplasm. The main drawback of the drugs currently in use is the low bioavailability caused by many pathophysiological and pharmaceutical factors. The aim of the present study was to develop new modifiedrelease topical products by encapsulating bexarotene into biocompatible silica matrices and by formulating...